| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 15.0K | 12.4% |
| Total Income | 15.0K | 12.4% |
| Expenditure | 11.0K | 14.6% |
| PBT | 1.0K | 37.5% |
| Net Profit | 695.00 | 46.0% |
| OPM | 26.60% | 1.38pp |
| NPM | 4.63% | 5.00pp |
| EPS | 0.39 | 45.8% |
AbbVie Inc. Reports Earnings for 2026
04 Apr 2026 · 4 Apr, 1:35 am
Summary
AbbVie Inc. announced its earnings for 2026. The report mentions adjustments to earnings per share guidance due to first-quarter acquired IPR&D and milestone expenses.
Key Highlights
- 1
Revenue: Not specified in provided text
- 2
Net Income: Not specified in provided text
- 3
EPS: Adjusted guidance due to IPR&D expenses
- 4
First quarter 2026 acquired IPR&D and milestones expense impacted earnings
Informational and educational content only. Not investment advice.